493 related articles for article (PubMed ID: 7494299)
21. Expression of the mouse mammary tumor virus long terminal repeat open reading frame promotes tumorigenic potential of hyperplastic mouse mammary epithelial cells.
Mukhopadhyay R; Medina D; Butel JS
Virology; 1995 Aug; 211(1):74-93. PubMed ID: 7645239
[TBL] [Abstract][Full Text] [Related]
22. Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines.
Lefebvre P; Berard DS; Cordingley MG; Hager GL
Mol Cell Biol; 1991 May; 11(5):2529-37. PubMed ID: 1708094
[TBL] [Abstract][Full Text] [Related]
23. Distinct sequence elements involved in the glucocorticoid regulation of the mouse mammary tumor virus promoter identified by linker scanning mutagenesis.
Buetti E; Kühnel B
J Mol Biol; 1986 Aug; 190(3):379-89. PubMed ID: 3023641
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of mouse mammary tumor virus superantigen expression by an intragenic enhancer.
Reuss FU; Coffin JM
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9293-7. PubMed ID: 7568120
[TBL] [Abstract][Full Text] [Related]
25. Stably integrated mouse mammary tumor virus long terminal repeat DNA requires the octamer motifs for basal promoter activity.
Buetti E
Mol Cell Biol; 1994 Feb; 14(2):1191-203. PubMed ID: 8289800
[TBL] [Abstract][Full Text] [Related]
26. Identification of a protein that recognizes a distal negative regulatory element within the mouse mammary tumor virus long terminal repeat.
Kang CJ; Peterson DO
Virology; 1999 Nov; 264(1):211-9. PubMed ID: 10544147
[TBL] [Abstract][Full Text] [Related]
27. TEF-1 transcription factors regulate activity of the mouse mammary tumor virus LTR.
Maeda T; Maeda M; Stewart AF
Biochem Biophys Res Commun; 2002 Sep; 296(5):1279-85. PubMed ID: 12207913
[TBL] [Abstract][Full Text] [Related]
28. A mouse mammary tumor virus mammary gland enhancer confers tissue-specific but not lactation-dependent expression in transgenic mice.
Mok E; Golovkina TV; Ross SR
J Virol; 1992 Dec; 66(12):7529-32. PubMed ID: 1331537
[TBL] [Abstract][Full Text] [Related]
29. Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter.
Archer TK; Lee HL; Cordingley MG; Mymryk JS; Fragoso G; Berard DS; Hager GL
Mol Endocrinol; 1994 May; 8(5):568-76. PubMed ID: 8058066
[TBL] [Abstract][Full Text] [Related]
30. A composite enhancer element directing tissue-specific expression of mouse mammary tumor virus requires both ubiquitous and tissue-restricted factors.
Grimm SL; Nordeen SK
J Biol Chem; 1999 Apr; 274(18):12790-6. PubMed ID: 10212264
[TBL] [Abstract][Full Text] [Related]
31. Hormonal response region in the mouse mammary tumor virus long terminal repeat can be dissociated from the proviral promoter and has enhancer properties.
Ponta H; Kennedy N; Skroch P; Hynes NE; Groner B
Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1020-4. PubMed ID: 2983325
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
33. Dual function of a nuclear factor I binding site in MMTV transcription regulation.
Buetti E; Kühnel B; Diggelmann H
Nucleic Acids Res; 1989 Apr; 17(8):3065-78. PubMed ID: 2542892
[TBL] [Abstract][Full Text] [Related]
34. Synergistic action of GA-binding protein and glucocorticoid receptor in transcription from the mouse mammary tumor virus promoter.
Aurrekoetxea-Hernández K; Buetti E
J Virol; 2000 Jun; 74(11):4988-98. PubMed ID: 10799572
[TBL] [Abstract][Full Text] [Related]
35. Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice.
Ross SR; Hsu CL; Choi Y; Mok E; Dudley JP
Mol Cell Biol; 1990 Nov; 10(11):5822-9. PubMed ID: 1700274
[TBL] [Abstract][Full Text] [Related]
36. Constitutive repression and nuclear factor I-dependent hormone activation of the mouse mammary tumor virus promoter in Saccharomyces cerevisiae.
Chávez S; Candau R; Truss M; Beato M
Mol Cell Biol; 1995 Dec; 15(12):6987-98. PubMed ID: 8524266
[TBL] [Abstract][Full Text] [Related]
37. The 5' enhancer of the mouse mammary tumor virus long terminal repeat contains a functional AP-2 element.
Mellentin-Michelotti J; John S; Pennie WD; Williams T; Hager GL
J Biol Chem; 1994 Dec; 269(50):31983-90. PubMed ID: 7989375
[TBL] [Abstract][Full Text] [Related]
38. Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.
Mertz JA; Mustafa F; Meyers S; Dudley JP
J Virol; 2001 Mar; 75(5):2174-84. PubMed ID: 11160721
[TBL] [Abstract][Full Text] [Related]
39. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of a tannic acid-responsive negative regulatory element in the mouse mammary tumor virus promoter.
Uchiumi F; Sato T; Tanuma S
J Biol Chem; 1998 May; 273(20):12499-508. PubMed ID: 9575208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
